Evidence map›Paper›PMID 25278753›Full record

ArticleInternational journal of nanomedicine2014

Short-time focused ultrasound hyperthermia enhances liposomal doxorubicin delivery and antitumor efficacy for brain metastasis of breast cancer.

Sheng-Kai Wu, Chi-Feng Chiang, Yu-Hone Hsu, Tzu-Hung Lin, Houng-Chi Liou, Wen-Mei Fu, Win-Li Lin

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Sheng-Kai WuInstitute of Biomedical Engineering, College of Medicine and College of Engineering, Taipei, Taiwan.
Chi-Feng ChiangInstitute of Biomedical Engineering, College of Medicine and College of Engineering, Taipei, Taiwan.
Yu-Hone HsuInstitute of Biomedical Engineering, College of Medicine and College of Engineering, Taipei, Taiwan ; Department of Neurosurgery, Cheng-Hsin General Hospital, Taipei, Taiwan.
Tzu-Hung LinInstitute of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Houng-Chi LiouInstitute of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Wen-Mei FuInstitute of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Win-Li LinInstitute of Biomedical Engineering, College of Medicine and College of Engineering, Taipei, Taiwan ; Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli, Taiwan.
National Taiwan University · TWInstitute of Biomedical Science · GBInstitute of Biomedical Sciences, Academia Sinica · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The blood-brain/tumor barrier inhibits the uptake and accumulation of chemotherapeutic drugs. Hyperthermia can enhance the delivery of chemotherapeutic agent into tumors. In this study, we investigated the effects of short-time focused ultrasound (FUS) hyperthermia on the delivery and therapeutic efficacy of pegylated liposomal doxorubicin (PLD) for brain metastasis of breast cancer. Murine breast cancer 4T1-luc2 cells expressing firefly luciferase were injected into female BALB/c mice striatum tissues and used as a brain metastasis model. The mice were intravenously injected with PLD (5 mg/kg) with/without 10-minute transcranial FUS hyperthermia on day 6 after tumor implantation. The amounts of doxorubicin accumulated in the normal brain tissues and tumor tissues with/without FUS hyperthermia were measured using fluorometry. The tumor growth for the control, hyperthermia, PLD, and PLD + hyperthermia groups was measured using an IVIS spectrum system every other day from day 3 to day 11. Cell apoptosis and tumor characteristics were assessed using immunohistochemistry. Short-time FUS hyperthermia was able to significantly enhance the PLD delivery into brain tumors. The tumor growth was effectively inhibited by a single treatment of PLD + hyperthermia compared with both PLD alone and short-time FUS hyperthermia alone. Immunohistochemical examination further demonstrated the therapeutic efficacy of PLD plus short-time FUS hyperthermia for brain metastasis of breast cancer. The application of short-time FUS hyperthermia after nanodrug injection may be an effective approach to enhance nanodrug delivery and improve the treatment of metastatic cancers.

Indexed as

AnimalsAntineoplastic AgentsApoptosisBrainBrain NeoplasmsBreast NeoplasmsCell Line, TumorCell ProliferationDoxorubicinDrug CarriersFemaleHyperthermia, InducedIn Situ Nick-End LabelingMiceMice, Inbred BALB CMicrobubblesAntineoplastic AgentsDoxorubicinDrug Carriersliposomal doxorubicinPolyethylene Glycolsbrain metastasis of breast cancerfocused ultrasound (FUS)hyperthermiapegylated liposomal doxorubicin (PLD)

Identifiers

PMID25278753
PMCPMC4178504
OpenAlexW2153687533

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.